In our research, both DPP4 activity and concentration were associated to more severe steatosis grade and inflammation at the biopsy whereas hepatic DPP4 expression was not influenced by liver damage in the course of NAFLD/NASH. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.